WADA organized its third Gene Doping Symposium in Saint Petersburg (Russia) on June 10-11, 2008, with the support of the Russian Sport Authorities (Rossport).
WADA would also like to thank the American Association for the Advancement of Science (AAAS) and the Greenwall Foundation in New York for their contribution to the Symposium.
This third Symposium, following on those held in 2002 in Banbury (U.S.) and in 2005 in Stockholm (Sweden), provided an opportunity to receive an update on the latest research activities and developments, consider the boundaries between therapy and enhancement from both technical and ethical perspectives, and address legal frameworks and law enforcement issues relating to gene doping. Attendees included experts in gene transfer, scientists from the field of anti-doping, WADA’s own Gene Doping Panel members, representatives from sports and public authorities, and ethicists.
Tuesday, 10 June 2008
- General Review of Current State of Development of Gene, Cell and Tissue Therapies (T. Friedmann)
- Overview of WADA Research Program for Gene Doping Detection (O. Rabin)
- Modern Techniques in Gene Research: Prospect and Applicability for the Detection of Gene Doping (A.S. Glotov/P.U. Dudkin)
- Is There a Distinction Between Therapy and Enhancement Worth Preserving? What Is It? (Eric Juengst)
Wednesday, 11 June 2008
- Commercialization of Gene Doping in Sports (Mark Frankel)
- Challenges for Policy Making for Gene Doping in the Sport Context (Barrie Houlihan)
- Legal Framework and Law Enforcement (David Howman)
- Ethics and Enhancement – Where Does Sport Lead Us? (Tom Murray)